HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fleming, D. J Articles by Wood, R. J Search for Related Content PubMed PubMed Citation Articles by Fleming, D. J Articles by Wood, R. J Agricola Articles by Fleming, D. J Articles by Wood, R. J

Aspirin intake and the use of serum ferritin as a measure of iron status^1,2,3,4

¹ From the Mineral Bioavailability Laboratory and the Epidemiology Program, Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston; The Framingham Heart Study, Framingham, MA; and Boston University Schools of Medicine and Public Health and Department of Mathematics and Statistics.

Background: Atherosclerosis, a primary cause of myocardial infarction (MI), is an inflammatory disease. Aspirin use lowers risk of MI, probably through antithrombotic and antiinflammatory effects. Because serum ferritin (SF) can be elevated spuriously by inflammation, reported associations between elevated SF, used as an indicator of iron stores, and heart disease could be confounded by occult inflammation and aspirin use if they affect SF independently of iron status.

Objective: We tested the hypothesis that aspirin use is associated with reduced SF.

Design: We used analysis of covariance to investigate the relation between SF and categories of aspirin use in 913 elderly participants aged 67–96 y in the Framingham Heart Study.

Results: After adjustment for sex, age, body mass index, smoking, alcohol use, concentrations of C-reactive protein and liver enzymes, white blood cell count, and use of nonaspirin nonsteroidal antiinflammatory drugs and other medications, subjects who took >7 aspirins/wk had a significantly lower (by 25%) geometric mean SF than did nonusers, who took <1 aspirin/wk (71 compared with 95 µg/L, respectively; P for trend = 0.004). This effect of aspirin on SF was more marked in diseased subjects than in healthy subjects (mean SF was 50% lower compared with 21% lower, respectively).

Conclusions: Aspirin use is associated with lower SF. We suggest this effect results from possible increased occult blood loss and a cytokine-mediated effect on SF in subjects with inflammation, infection, or liver disease. The relations between aspirin, inflammation, and SF may confound epidemiologic associations between elevated SF, as an indicator of iron stores, and heart disease risk.

Key Words: Aspirin • serum ferritin • myocardial infarction • elderly • cytokine • C-reactive protein • inflammation • iron stores • epidemiology • atherosclerosis • antiinflammatory

This article has been cited by other articles:

				A.-L. M. Heath, M. A. Roe, S. L. Oyston, A. R. Gray, S. M. Williams, and S. J. Fairweather-Tait Blood Loss Is a Stronger Predictor of Iron Status in Men Than C282Y Heterozygosity or Diet J. Am. Coll. Nutr., February 1, 2008; 27(1): 158 - 167. [Abstract] [Full Text] [PDF]

				J. L Sullivan The Big Idea: the coxib crisis Iron, aspirin and heart disease risk revisited J R Soc Med, July 1, 2007; 100(7): 346 - 349. [Full Text] [PDF]

				R. Hammerman-Rozenberg, J. M. Jacobs, D. Azoulay, and J. Stessman Aspirin prophylaxis and the prevalence of anaemia Age Ageing, September 1, 2006; 35(5): 514 - 517. [Abstract] [Full Text] [PDF]

				N. W Solomons and K. Schumann Intramuscular administration of iron dextran is inappropriate for treatment of moderate pregnancy anemia, both in intervention research on underprivileged women and in routine prenatal care provided by public health services Am. J. Clinical Nutrition, January 1, 2004; 79(1): 1 - 3. [Full Text] [PDF]

				J.-M. Liu, S. E Hankinson, M. J Stampfer, N. Rifai, W. C Willett, and J. Ma Body iron stores and their determinants in healthy postmenopausal US women Am. J. Clinical Nutrition, December 1, 2003; 78(6): 1160 - 1167. [Abstract] [Full Text] [PDF]

				G. Ramakrishna, T. W Rooke, and L. T Cooper Iron and peripheral arterial disease: revisiting the iron hypothesis in a different light Vascular Medicine, August 1, 2003; 8(3): 203 - 210. [Abstract] [PDF]

				D. J Fleming, K. L Tucker, P. F Jacques, G. E Dallal, P. W. Wilson, and R. J Wood Dietary factors associated with the risk of high iron stores in the elderly Framingham Heart Study cohort Am. J. Clinical Nutrition, December 1, 2002; 76(6): 1375 - 1384. [Abstract] [Full Text] [PDF]